Contracts & Pricing June 29, 2021 SPTR, CMS Final Rule & VA Public Law Updates 5 Minute Read The latest regulatory updates and reporting reminders for June 2021.
ICyte Platform June 17, 2021 Operational Goals to Future Proof Market Access 3 Minute Read In this third installment, we look at operational goals for Market Access. Commercial Operations and Contracting teams need a flexible infrastructure that can support business scale and the changing...
Patient Access June 14, 2021 Frequently Asked Questions – Patient Tokenization 3 Minute Read Patient tokenization is one of the most mysterious, least understood, and most essential technologies behind actionable patient data. Taken from the Q&A session of IntegriChain's recent Patient Tokenization webinar....
ICyte Platform June 3, 2021 Financial Goals to Future Proof Market Access 3 Minute Read In this four-part series, we examine the key goals of Market Access teams as they look to the future with the advent of speciality and precision medicine and how...
Contracts & Pricing May 27, 2021 Making Sense of Co-Pay Offset Programs 4 Minute Read We dive into the specifics of co-pay offset programs and also examine updates to 340B administrative dispute resolution and ASP reporting as per H.R. 133.
ICyte Platform May 20, 2021 Future Proofing Market Access with a Unified Data and Technology Platform 4 Minute Read This is the first of a series examining the commercial, financial, and operational goals of Market Access, which are all are stymied by data and application silos.
Contracts & Pricing April 21, 2021 Updates to State Price Transparency Reporting, Medicaid Laws 3 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing April 14, 2021 The Current State of Drug Price Transparency Reporting 2 Minute Read What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk.
Contracts & Pricing March 11, 2021 Changes to Medicare Part D, Drug Rebate Program, OIG Final Rule 5 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
